When tested in a mouse model with syngeneic Lewis lung carcinoma, NHS-IL2 alone did not exhibit any significant effect on tumor growth, but the combination with cisplatin (a chemotherapy drug) and radiotherapy resulted in marked tumor size reduction. Here, IL2 is linked to neoplasm.